Solubility of chlorpheniramine maleate in supercritical carbon dioxide

Chattopadhyay, 2001, Production of antibiotic nanoparticles using supercritical CO2 as antisolvent with enhanced mass transfer, Industrial and Engineering Chemistry Research, 40, 3530, 10.1021/ie010040r

Kalogiannis, 2005, Production of amoxicillin microparticles by supercritical antisolvent precipitation, Industrial and Engineering Chemistry Research, 44, 9339, 10.1021/ie050654m

Rehman, 2011, Solubility and precipitation of nicotinic acid in supercritical carbon dioxide, Journal of Pharmaceutical Science, 90, 1570, 10.1002/jps.1107

Velaga, 2002, Preparation and characterisation of hydrocortisone particles using a supercritical fluids extraction process, International Journal of Pharmaceutics, 231, 155, 10.1016/S0378-5173(01)00870-5

Yeo, 2004, Crystallization of sulfamethizole using the supercritical and liquid antisolvent processes, J. Supercritical Fluids, 30, 315, 10.1016/j.supflu.2003.09.005

He, 2004, Precipitation of ephedrine by SEDS process using a specially designed prefilming atomizer, J. Supercritical Fluids, 31, 101, 10.1016/j.supflu.2004.01.009

Matson, 1987, Rapid expansion of supercritical fluid solutions: solute formation of powders, thin films, and fibers, Industrial and Engineering Chemistry Research, 26, 2298, 10.1021/ie00071a021

Jung, 2001, Particle design using supercritical fluids: literature and patent survey, J. Supercritical Fluids, 20, 179, 10.1016/S0896-8446(01)00064-X

Mawson, 1995, Formation of poly(1,1,2,2-tetrahydroperfluorodecyl acrylate) submicron fibers and particles from supercritical carbon dioxide solutions, Macromolecules, 28, 3182, 10.1021/ma00113a021

Yildiz, 2007, Micronization of salicylic acid and taxol (paclitaxel) by rapid expansion of supercritical fluids (RESS), J. Supercritical Fluids, 41, 440, 10.1016/j.supflu.2006.12.012

Perrut, 2005, Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I. Micronization of neat particles, International Journal of Pharmaceutics, 288, 3, 10.1016/j.ijpharm.2004.09.007

Zeinolabedini Hezave, 2011, The effects of RESS parameters on the diclofenac particle size, Advanced Powder Technology, 22, 587, 10.1016/j.apt.2010.08.010

Zeinolabedini Hezave, 2012, Recrystallization of microparticles of fenoprofen using rapid expansion of supercritical solution, J. Dispersion Science and Technology, 33, 1106, 10.1080/01932691.2011.599231

Zeinolabedini Hezave, 2010, Crystallization of micro particles of sulindac using rapid expansion of supercritical solution, J. Crystal Growth, 312, 3373, 10.1016/j.jcrysgro.2010.07.033

Zeinolabedini Hezave, 2010, Micronization of drug particles via RESS process, J. Supercritical Fluids, 52, 84, 10.1016/j.supflu.2009.09.006

Zeinolabedini Hezave, 2010, Investigation of the rapid expansion of supercritical solution parameters effects on size and morphology of cephalexin particles, J. Aerosol Science, 41, 1090, 10.1016/j.jaerosci.2010.08.004

Zeinolabedini Hezave, 2010, Micronization of ketoprofen by the rapid expansion of supercritical solution process, J. Aerosol Science, 41, 821, 10.1016/j.jaerosci.2010.01.006

Johannsen, 1995, Measurements of solubilities of xanthines in supercritical carbon dioxide+methanol, J. Chemical & Engineering Data, 40, 431, 10.1021/je00018a016

Su, 2008, Measurement and correlation for the solid solubility of nonsteroidal anti-inflammatory drugs (NSAIDs) in supercritical carbon dioxide, J. Supercritical Fluids, 43, 438, 10.1016/j.supflu.2007.08.006

Vedaraman, 2004, Solubility of N-CBZ derivatised amino acids in supercritical carbon dioxide, J. Supercritical Fluids, 30, 119, 10.1016/j.supflu.2003.07.005

Guclu-Ustundag, 2000, Correlating the solubility behavior of fatty acid, mono-, di, and triglycerides and fatty acid esters in supercritical carbon dioxide, Industrial & Engineering Chemistry Research, 39, 4756, 10.1021/ie0001523

Mendez-Santiago, 1999, The solubility of solids in supercritical fluids, Fluid Phase Equilibria, 158–160, 501, 10.1016/S0378-3812(99)00154-5

Huang, 2005, Representing dyestuff solubility in supercritical carbon dioxide with several density-based correlations, Fluid Phase Equilibria, 236, 136, 10.1016/j.fluid.2005.07.012

Zeinolabedini Hezave, 2011, Cetirizine solubility in supercritical CO2 at different pressures and temperatures, J. Supercritical Fluids, 58, 198, 10.1016/j.supflu.2011.05.017

Zeinolabedini Hezave, 2012, Solubility of sulindac in the supercritical carbon dioxide: experimental and modeling approach, J. Supercritical Fluids, 68, 39, 10.1016/j.supflu.2012.04.006

Zeinolabedini Hezave, 2012, Measurement and modeling of mefenamic acid solubility in supercritical carbon dioxide, Fluid Phase Equilibria, 313, 140, 10.1016/j.fluid.2011.09.031

Zeinolabedini Hezave, 2012, Solubility measurement of diclofenac acid in the supercritical CO2, J. Chemical & Engineering Data, 57, 1659, 10.1021/je200012x

Rajaei, 2013, Representing experimental solubility of phenylephrine hydrochloride in supercritical carbon dioxide and modeling solute solubility using semi-empirical correlations, J. Supercritical Fluids, 75, 181, 10.1016/j.supflu.2012.11.014

Zeinolabedini Hezave, 2013, Analyzing the solubility of fluoxetine hydrochloride in supercritical carbon dioxide, J. Supercritical Fluids, 73, 57, 10.1016/j.supflu.2012.11.005

Coimbra a, 2006, Cubic equation-of-state correlation of the solubility of some anti-inflammatory drugs in supercritical carbon dioxide, Fluid Phase Equilibria, 239, 188, 10.1016/j.fluid.2005.11.028

Ashour, 2000, Representation of solid supercritical fluid phase equilibria using cubic equations of state, Fluid Phase Equilibria, 167, 41, 10.1016/S0378-3812(99)00314-3

Tsivintzelis, 2009, Modeling the phase behavior in mixtures of pharmaceuticals with liquid or supercritical solvents, J. Physical Chemistry B, 113, 6446, 10.1021/jp807952v

Guha, 2001, Modeling of ternary solubilities of organics in supercritical carbon dioxide, Fluid Phase Equilibria, 187, 255, 10.1016/S0378-3812(01)00540-4

Bartle, 1991, Solubilities of solids and liquids of low volatility in supercritical carbon dioxide, J. Physical Chemistry Reference Data, 20, 713, 10.1063/1.555893

Chrastil, 1982, Solubility of solids and liquids in supercritical gases, J. Physical Chemistry, 86, 3016, 10.1021/j100212a041

Kumar, 1988, Modeling the solubility of solids and liquids in supercritical fluids, using density as the independent variable, J. Supercritical Fluids, 1, 15, 10.1016/0896-8446(88)90005-8

Tabernero, 2010, A comparison between semiempirical equations to predict the solubility of pharmaceutical compounds in supercritical carbon dioxide, J. Supercritical Fluids, 52, 161, 10.1016/j.supflu.2010.01.009

Stassi, 2000, Assessment of solubility of ketoprofen and vanillic acid in supercritical CO2 under dynamic conditions, J. Chemical Engineering Data, 45, 161, 10.1021/je990114u

Macnaughton, 1996, Solubility of anti-inflammatory drugs in supercritical carbon dioxide, J. Chemical Engineering Data, 41, 1083, 10.1021/je960103q

Yamini, 1998, Solubility of dihydroxybenzene isomers in supercritical carbon dioxide, Fluid Phase Equilibria, 152, 299, 10.1016/S0378-3812(98)00385-9

Kurnik, 1981, Solubility extrema in solid-fluid equilibria, AIChE J., 27, 861, 10.1002/aic.690270528

Kraska, 2002, Correlation of the solubility of low-volatile organic compounds in near- and supercritical fluids. Part I: applications to adamantane and β-carotene, J. Supercritical Fluids, 23, 209, 10.1016/S0896-8446(02)00003-7